1.67
+0.06(+3.73%)
Currency In USD
| Previous Close | 1.61 |
| Open | 1.64 |
| Day High | 1.7 |
| Day Low | 1.58 |
| 52-Week High | 7.74 |
| 52-Week Low | 1.3 |
| Volume | 48,259 |
| Average Volume | 310,442 |
| Market Cap | 3M |
| PE | -0.7 |
| EPS | -2.4 |
| Moving Average 50 Days | 1.72 |
| Moving Average 200 Days | 2.98 |
| Change | 0.06 |
If you invested $1000 in Bone Biologics Corporation (BBLG) since IPO date, it would be worth $0.5 as of January 16, 2026 at a share price of $1.67. Whereas If you bought $1000 worth of Bone Biologics Corporation (BBLG) shares 3 years ago, it would be worth $7.36 as of January 16, 2026 at a share price of $1.67.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook
GlobeNewswire Inc.
Jan 08, 2026 1:00 PM GMT
Key accomplishments include expanded rhNELL-1 shelf life, advanced NB1 development, strengthened balance sheet, and maintained Nasdaq complianceBURLINGTON, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone Biologics" or the
Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months
GlobeNewswire Inc.
Dec 23, 2025 1:00 PM GMT
Milestone advances manufacturing readiness and supports long-term commercialization strategyBURLINGTON, Mass., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ: BBLG, BBLGW), a developer of or